Zobrazeno 1 - 10
of 12
pro vyhledávání: '"John C W Lim"'
Publikováno v:
BMJ Global Health, Vol 5, Iss 9 (2020)
Externí odkaz:
https://doaj.org/article/fcee4f52d759460a87959f6f3380852a
Autor:
Alexander R Giaquinto, Alberto Grignolo, Lawrence Liberti, John C W Lim, Tomas Salmonson, Fernand Sauer, Henrietta Ukwu
Publikováno v:
PLoS Medicine, Vol 17, Iss 8, p e1003092 (2020)
Alexander Giaquinto and co-authors discuss the East African Community's Medicines Regulatory Harmonization initiative.
Externí odkaz:
https://doaj.org/article/6aea43aca56d457aade0303ba75b9eff
Autor:
Lukas Roth, Daniel Bempong, Joseph B. Babigumira, Shabir Banoo, Emer Cooke, David Jeffreys, Lombe Kasonde, Hubert G. M. Leufkens, John C. W. Lim, Murray Lumpkin, Gugu Mahlangu, Rosanna W. Peeling, Helen Rees, Margareth Ndomondo-Sigonda, Andy Stergachis, Mike Ward, Jude Nwokike
Publikováno v:
Globalization and Health, Vol 14, Iss 1, Pp 1-12 (2018)
Abstract Access to quality-assured medical products improves health and save lives. However, one third of the world’s population lacks timely access to quality-assured medicines while estimates indicate that at least 10% of medicine in low- and mid
Externí odkaz:
https://doaj.org/article/62d88c7f5c5347a086f5f50187962217
Publikováno v:
AAPS Open, Vol 4, Iss 1, Pp 1-8 (2018)
Abstract Regulatory convergence and cooperation among the authorities in the field of medical products (medicines and medical devices) are essential to deliver safe and efficacious products quickly to patients. APEC established the Regulatory Harmoni
Externí odkaz:
https://doaj.org/article/b6a2bb6a9ff9479faa26a25b15af3bc3
Publikováno v:
Clinical Pharmacology & Therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd1b1fcc3a14438066037bdbd8a607e4
https://doi.org/10.1002/cpt.2889
https://doi.org/10.1002/cpt.2889
Publikováno v:
Current medical research and opinion. 38(9)
To provide recommendations for overcoming the challenges associated with the generation and use of real-world evidence (RWE) in regulatory approvals, health technology assessments (HTAs), and reimbursement decision-making in East Asia.A panel of expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b218ba81b94beaebac590010a1cb982
https://pubmed.ncbi.nlm.nih.gov/35786170
https://pubmed.ncbi.nlm.nih.gov/35786170
Publikováno v:
BMJ Global Health
BMJ Global Health, Vol 5, Iss 9 (2020)
BMJ Global Health, Vol 5, Iss 9 (2020)
Summary box The COVID-19 outbreak among migrant workers in Singapore has revealed the health disparities of migrant workers due to suboptimal living conditions and poor access to ambulatory healthcare. This has given Singapore the impetus to start di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de9a32692a96d128132ca4a765aa699f
https://pubmed.ncbi.nlm.nih.gov/32873597
https://pubmed.ncbi.nlm.nih.gov/32873597
Publikováno v:
Clinical Pharmacology & Therapeutics. 105:805-808
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46bf884e8da560003fbfb68453f1bfe
https://doi.org/10.1002/cpt.1253
https://doi.org/10.1002/cpt.1253
Autor:
John C W Lim
Publikováno v:
Therapeutic innovationregulatory science. 52(6)
Asia-Pacific is a region of fast growing opportunity for biomedical research and marketing of new health products by pharmaceutical and medical device companies. While national regulatory authorities have the responsibility to ensure timely access to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32b0ca31d22d114aa090cdae563a3deb
https://pubmed.ncbi.nlm.nih.gov/29714589
https://pubmed.ncbi.nlm.nih.gov/29714589
Autor:
Lynn G. Baird, E. V. Sigal, Jeffrey S. Brown, D. Tan, Robyn Lim, H. G. Eichler, Kenneth A. Oye, Vicki L. Seyfert-Margolis, E Pezalla, J Ferguson, Brian O'Rourke, Sarah Garner, J. Sobotka, John C W Lim, Chester L. Drum, Thomas F. Unger, P. Honig, Diane Shoda, Mathias Hukkelhoven, G. Neil, E. Abadie, M. M. Lumpkin, Gigi Hirsch
Publikováno v:
Clinical Pharmacology & Therapeutics. 91:426-437
Traditional drug licensing approaches are based on binary decisions. At the moment of licensing, an experimental therapy is presumptively transformed into a fully vetted, safe, efficacious therapy. By contrast, adaptive licensing (AL) approaches are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245a5f02aea1ed485744329305690ab5
https://doi.org/10.1038/clpt.2011.345
https://doi.org/10.1038/clpt.2011.345